Sign In
Buy SAN
$14.10
-0.0100 (-0.0709%)
At Close: Jul 31, 2026
Amgen wins battle for Horizon Therapeutics, bolstering its rare-disease portfolio
12:47pm, Tuesday, 13'th Dec 2022 MarketWatch
Amgen Inc. is acquiring Dublin-based Horizon Therapeutics in a roughly $28 billion deal that is the biggest in the healthcare sector in 2022.
Amgen reportedly in talks to buy Horizon Therapeutics
06:36am, Monday, 12'th Dec 2022 MarketWatch
The U.S. biotechnology company AMGN was the last of three suitors standing in an auction for Horizon, according to sources cited by The Wall Street Journal.
Press Release: Statement from Sanofi regarding Horizon Therapeutics plc (“Horizon”)
06:21pm, Sunday, 11'th Dec 2022 GlobeNewswire Inc.
Communiqué de presse : Annonce de Sanofi au sujet de Horizon Therapeutics plc (“Horizon”)
06:21pm, Sunday, 11'th Dec 2022 GlobeNewswire Inc.Santander UK fined £107mln by financial regulator FCA for anti-money laundering failures
03:47am, Friday, 09'th Dec 2022
The UK arm of Spanish banking group Banco Santander has been fined £107.79mln by the Financial Conduct Authority (FCA) after the regulator found “serious and persistent gaps” in the bank's anti-
Santander U.K. fined $131.4 million for anti-money-laundering failures
02:56am, Friday, 09'th Dec 2022
According to the FCA, Santander UK PLC has failed to properly oversee and manage its AML systems between December 2012 and October 2017, which affected the account oversight of more than 560,000 busin
Banco Santander: Trading At 5x Earnings And A 35% Discount To Its TBV
11:35am, Saturday, 03'rd Dec 2022
Banco Santander generates almost 70% of its income outside of Europe. The earnings remain strong, and the bank has a shot at a full-year EPS of 0.55 EUR per share.
Press Release: Statement from Sanofi regarding: rule 2.12 of the takeover rules
06:55am, Friday, 02'nd Dec 2022 GlobeNewswire Inc.
Communiqué de presse : Annonce de Sanofi au sujet de la règle 2.12 des "takeover rules"
06:55am, Friday, 02'nd Dec 2022 GlobeNewswire Inc.
Banks are short more than $1 trillion in capital, says this analyst, who fears the shortfall will only get worse
01:37pm, Wednesday, 30'th Nov 2022 MarketWatch
If bank assets are marked to market, the U.S. sector is insolvent, according to an independent analyst.
Press Release: Acoziborole: Investigational single-dose oral treatment raises hope for elimination of sleeping sickness in Africa
07:00am, Wednesday, 30'th Nov 2022 GlobeNewswire Inc.
Acoziborole: Investigational single-dose oral treatment raises hope for elimination of sleeping sickness in Africa
Communiqué de presse : Acoziborole : un médicament expérimental oral et à dose unique pourrait permettre d’éliminer la maladie du sommeil en Afrique
07:00am, Wednesday, 30'th Nov 2022 GlobeNewswire Inc.
Acoziborole : un médicament expérimental oral et à dose unique pourrait permettre d’éliminer la maladie du sommeil en Afrique
Press Release: European Commission approves Enjaymo® (sutimlimab) for treatment of hemolytic anemia in adult patients with cold agglutinin disease
05:50pm, Thursday, 17'th Nov 2022 GlobeNewswire Inc.
European Commission approves Enjaymo® (sutimlimab) for treatment of hemolytic anemia in adult patients with cold agglutinin disease
Communiqué de presse: La Commission européenne approuve Enjaymo® (sutimlimab) pour le traitement de l’anémie hémolytique de l’adulte atteint de la maladie des agglutinines froides
05:50pm, Thursday, 17'th Nov 2022 GlobeNewswire Inc.
La Commission européenne approuve Enjaymo® (sutimlimab) pour le traitement de l’anémie hémolytique de l’adulte atteint de la maladie des agglutinines froides
Sanofi: Informations relatives au nombre de droits de vote et d'actions - Octobre 2022
10:42pm, Monday, 14'th Nov 2022 GlobeNewswire Inc.
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marc
